| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/11/2009 | US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/11/2009 | US7572921 Substituted benzylimidazoles useful for the treatment of inflammatory diseases |
| 08/11/2009 | US7572920 Benzimidazole derivative and use as a II receptor antagonist |
| 08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/11/2009 | US7572826 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572820 Chemical compounds |
| 08/11/2009 | US7572794 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572792 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572788 Compositions and methods relating to novel compounds and targets thereof |
| 08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/11/2009 | US7572785 Substituted imidazoles as cannabinoid receptor modulators |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2362385C Heterodiazinon compound |
| 08/11/2009 | CA2320120C Benzisoxazole derivatives having d4-antagonistic activity |
| 08/06/2009 | WO2009097486A1 OXAZOLE-PYRROLE-PIPERAZINE α-HELIX MIMETIC |
| 08/06/2009 | WO2009095394A1 Diazepanes as histamine h3 receptor antagonists |
| 08/06/2009 | WO2009095377A1 Spiro compounds as npy y5 receptor antagonists |
| 08/06/2009 | WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids |
| 08/06/2009 | WO2009074950A3 Thiophene derivatives as agonists of s1p1/edg1 |
| 08/06/2009 | US20090198054 Preparation of thiazoles |
| 08/06/2009 | US20090198053 Pyrazine Derivatives and Uses Thereof in Renal Monitoring |
| 08/06/2009 | US20090198052 Method for preparing optically active piperidine compounds |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090197926 Benzimidazoles and their use for the treatment of diabetes |
| 08/06/2009 | US20090197897 Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 08/06/2009 | US20090197895 Oxazole-pyrrole-piperazine alpha-helix mimetic |
| 08/06/2009 | US20090197886 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 08/06/2009 | US20090197884 Compounds Useful as Antagonists of CCR2 |
| 08/06/2009 | US20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use |
| 08/06/2009 | US20090197882 Indazole derivatives for the treatment of hsp90-induced diseases |
| 08/06/2009 | US20090197880 Anti-viral compounds, compositions, and methods of use |
| 08/06/2009 | US20090197879 Vanilloid receptor ligands and their use in treatments |
| 08/06/2009 | US20090197875 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 08/06/2009 | US20090197866 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 08/06/2009 | US20090197863 Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/06/2009 | US20090197862 2-aminopyridine kinase inhibitors |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/06/2009 | US20090196912 Pyridinylamines |
| 08/05/2009 | EP2085394A2 Metronidazole derivatives as antiparasitic agents |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2084154A1 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 08/05/2009 | EP2084152A2 Substituted 4-imidazoles |
| 08/05/2009 | EP2084151A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 08/05/2009 | EP2084148A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 08/05/2009 | EP2084147A1 Heterocyclic fxr binding compounds |
| 08/05/2009 | EP2084140A1 Arginine derivatives with np-i antagonistic activity |
| 08/05/2009 | EP2029559B1 Aryl-4-ethynyl-isoxazole derivatives |
| 08/05/2009 | EP1984354B1 Pesticides containing a bicyclic bisamide structure |
| 08/05/2009 | EP1888541B1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands |
| 08/05/2009 | EP1844041A4 An improved process for the preparation of mycophenolate mofetil |
| 08/05/2009 | EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/05/2009 | EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 08/05/2009 | EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 08/05/2009 | EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents |
| 08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | CN101501031A Oxazolidone derivatives as pr modulators |
| 08/05/2009 | CN101501030A Pyrimidine derivatives useful in the treatment of cancer |
| 08/05/2009 | CN101501029A Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide |
| 08/05/2009 | CN101501028A 2-(heterocyclylbenzyl)-pyridazinonderivate |
| 08/05/2009 | CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 08/05/2009 | CN101501020A Nitrate esters of piperidines |
| 08/05/2009 | CN101501017A Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide |
| 08/05/2009 | CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators |
| 08/05/2009 | CN101497609A Process for preparing furaltadone hydrochloride |
| 08/05/2009 | CN101497602A Anthranilic acid compound and use thereof |
| 08/05/2009 | CN100522960C Thioamide derivatives as progesterone receptor modulators |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522161C (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 08/04/2009 | US7569688 Propane-1, 3-dione derivative |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome |
| 08/04/2009 | US7569578 Heterocyclic anti-migraine agents |
| 08/04/2009 | US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/04/2009 | US7569564 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 08/04/2009 | US7569561 For treating carcinoma chosen from cervical, breast, colon, head and neck, lung, pancreas, prostate, sarcomas, leukaemias, lymphomas, melanomas and gliomas |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 08/04/2009 | CA2496476C Therapeutic use |
| 07/30/2009 | WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | WO2009094028A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | WO2009093269A1 Novel heterocyclic compounds |
| 07/30/2009 | WO2009093049A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | WO2009092324A1 Oxazolidine derivatives as nmda antagonists |
| 07/30/2009 | WO2009053737A3 Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
| 07/30/2009 | WO2009051956A3 Pyrazole-substituted isoxazoline insecticides |
| 07/30/2009 | WO2009018925A8 Herbicide triazolylpyridine ketones |
| 07/30/2009 | WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof |
| 07/30/2009 | WO2009006404A3 Heterocyclic compounds useful as raf kinase inhibitors |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | US20090192197 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate |
| 07/30/2009 | US20090192196 Fungicide hydroximoyl-tetrazole derivatives |